The effect of tiotropium in combination with olodaterol on house dust mite-induced allergic airway disease-Reference-Cited by-同舟云学术

The effect of tiotropium in combination with olodaterol on house dust mite-induced allergic airway disease

Published:2017-08 Issue: Volume:45 Page:210-217
ISSN:1094-5539
Container-title:Pulmonary Pharmacology & Therapeutics
language:en
Short-container-title:Pulmonary Pharmacology & Therapeutics

Author:

John-Schuster Gerrit,de Kleijn Stan,van Wijck Yolanda^ORCID,Kremer Veerle,Smits Hermelijn H.,Pieper Michael P.,Hiemstra Pieter S.^ORCID,Taube Christian

Publisher

Elsevier BV

Subject

Pharmacology (medical),Biochemistry (medical),Pulmonary and Respiratory Medicine

Reference45 articles.

1. Global Strategy for Asthma Management and Prevention;Global Initiative for Asthma,2016

2. Pathobiology of severe asthma;Trejo Bittar;Annu. Rev. Pathol.,2015

3. Tiotropium bromide: a new long-acting bronchodilator for the treatment of chronic obstructive pulmonary disease;Koumis;Clin. Ther.,2005

4. A 4-year trial of tiotropium in chronic obstructive pulmonary disease;Tashkin;N. Engl. J. Med.,2008

5. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary;Vestbo;Am. J. Respir. Crit. Care Med.,2013

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Long-Acting Antimuscarinic Agents in the Treatment of Asthma;Journal of Aerosol Medicine and Pulmonary Drug Delivery;2023-08-01

2. Muscarinic Receptor Antagonism and Allergen Induced Airway Responses in Allergic Asthma: A Scoping Review;Clinical and Investigative Medicine;2022-06-26

3. Muscarinic receptor antagonists and airway inflammation: A systematic review on pharmacological models;Heliyon;2022-06

4. Long-Term Exposure to Sulfur Dioxide Before Sensitization Decreased the Production of Specific IgE in HDM-Sensitized Allergic Rhinitis Mice;Journal of Inflammation Research;2022-04

5. Synergy across the drugs approved for the treatment of asthma;Minerva Medica;2022-03